Merck Reveals Details on U.S. Drug-Pricing Practices

The average list-price increase across Merck’s brand-name drugs and vaccines ranged from 7.4% in 2010 to a peak of 10.5% in 2014, although the company did offer discounts.

from WSJ.com: US Business http://ift.tt/2jwXaU3
via IFTTT